Medical Devices Startups

Rheumasense develops clinical diagnostic testing technology aimed at transforming the management and care of rheumatoid arthritis. The company is advancing its diagnostic platform toward FDA submission and commercialization.

1 investor

Rheyo manufactures a light-activated chairside whitening system for dental practices, distributed through a pilot program model where practices receive the device free and pay per-use for consumable kits.

1 investor

RhoDx develops cell-free DNA and RNA enrichment technologies for liquid biopsy cancer diagnostics. The company provides ultra-sensitive mutation detection methods to improve the performance and accessibility of liquid biopsy testing.

1 investor

Rhovica Neuroimaging AG develops a patented navigation system for safe placement of brain catheters in acute cerebral hemorrhage cases, enabling real-time monitoring and bedside treatment in emergency settings. The company serves hospitals and emergency care providers in the medical device and neurosurgery sector.

1 investor

Rhythmlink designs and manufactures medical devices and provides contract manufacturing services for neurodiagnostic equipment, serving healthcare providers and diagnostic centers. The company specializes in physical connections between patients and neurophysiologic recording equipment.

1 investor

RIGImmune is a biotechnology company developing stem loop RNA (SLR) therapeutics that activate the RIG-I innate immune sensor and the Type I interferon pathway for use against serious respiratory diseases. It operates a non-lipid-nanoparticle delivery platform called NEED (Nano-Emulsion Enhanced Delivery) for delivering RNA therapeutics directly to the respiratory tract.

1 investor

RIN Institute develops antibody-based pharmaceuticals and in vitro diagnostic drugs for medical research and clinical use. The company was spun out from Japan's National Cancer Center.

1 investor

Risk Sciences International is a boutique consulting firm specializing in risk assessment, management, and communication for organizations across private, public, and civil sectors. The firm serves multinational corporations, federal governments, multilateral organizations, and community-level clients addressing risks to health, infrastructure, environment, and regulatory compliance.

1 investor

RiskLick develops Protocol AI, an AI-powered software platform for designing and developing clinical trial protocols and study plans to accelerate drug development timelines. The platform serves pharmaceutical companies and clinical research organizations seeking to reduce time to market and improve protocol quality.

1 investor

Ritivel builds an AI-native platform that automates regulatory workflows and documentation for life sciences companies, helping accelerate the submission of therapies to patients.

1 investor

HRSoft is a provider of enterprise compensation management software that enables organizations to design, manage, and automate complex pay programs including merit, bonus, equity, and incentive plans. The platform integrates with leading HRIS systems and serves large enterprises navigating complex global compensation structures.

1 investor

River Biomedics develops human cardiac in vitro models used for drug target and compound validation, building a pipeline of cardiac therapies. It focuses on treatments for cardiac diseases by targeting biological processes involved in their pathology.

1 investor

River is developing a speech brain-computer interface (BCI) that operates without touching the brain, aimed at restoring and augmenting human communication. The company collaborates with academic and clinical research partners in neuroscience and neural engineering.

1 investor

RiverD designs and manufactures non-invasive skin analysis devices based on Raman spectroscopy technology for scientific research, clinical applications, and industrial use. The company's instruments provide precise insights into skin composition and topical product penetration.

1 investor

Riverdale Healthcare is a dental healthcare provider offering oral surgery and related dental services including tooth removal, implants, and sedation procedures. The practice serves patients requiring specialized oral and maxillofacial surgery care.

1 investor

Robbie provides vision AI for healthcare facilities that monitors patient environments in real-time and predicts adverse events like falls. The platform uses face and body mesh analysis to detect risks across hospitals, behavioral health facilities, skilled nursing, and home care settings without requiring wearables or video storage.

1 investor

Roca Therapeutics develops first-in-class small molecule therapies for patients with neovascular retinal diseases. Founded in 2021 as a spin-off from Nice University and SATT Sud Est, the company is a biotech focused on ophthalmology drug development based in Nice, France.

1 investor

roclub (Remote Operations Club) provides a cloud-based SaaS platform for remote operation of MRI and CT scanners, letting radiology staff control imaging devices and support colleagues from other locations, along with a marketplace to book external medical-technical specialists. It serves healthcare organizations in diagnostic imaging, connecting scanners from all manufacturers, with initial focus on Germany and Switzerland.

1 investor

Rocoto Solutions engineers wireless video systems for medical and industrial environments where latency, signal integrity, and regulatory compliance are critical. The company's technology has been validated in over 30,000 operating rooms globally and serves hospitals, research centers, and industrial operators.

1 investor

Rodenstock is a German medical technology company and manufacturer of spectacle lenses that measures individual eyes using thousands of biometric data points to produce customized lenses. It sells its lenses through a network of partner opticians and provides consumers with online consultation and optician-search tools.

1 investor

Rohrer Aesthetics manufactures energy-based aesthetic devices for medical practitioners, offering solutions designed to enhance patient outcomes while maintaining affordability and practice profitability.

1 investor

Roka Bioscience develops molecular testing assays and automated instrument systems for rapid pathogen detection in food manufacturing. The company serves food safety professionals and manufacturers seeking to reduce contamination risks and improve laboratory efficiency.

1 investor

Rose Pharma is a pharmaceutical company developing therapies in gastroenterology and metabolic disorders. Led by experienced executives from major pharmaceutical firms, the company operates in the medtech/biotech sectors.

1 investor

Rosebud Biosciences develops therapies for rare genetic diseases in children by creating organoid models that replicate patient genetic mutations and using drug screening to identify potential cures. The company uses human-derived organoids combined with robotics and machine learning to accelerate drug discovery across cardiac, hepatic, neural, and kidney disease targets.

1 investor